Africa Corporate Wellness Market, by End User, 2018-2027
Global Heart Failure Drugs market [2016-2025] South America by Type
By Type, the market is segmented into Angiotensin Receptor Neprilysin Inhibitors, Angiotensin Receptor Blockers, Angiotensin-Converting Enzyme Inhibitors, Beta Blockers, Diuretics, and Others (2016-2025)
| Label | Angiotensin Receptor Neprilysin Inhibitors | Angiotensin Receptor Blockers | Angiotensin-Converting Enzyme Inhibitors | Beta Blockers | Diuretics | Others |
|---|---|---|---|---|---|---|
| 2016 | 70.99 USD Mn | 64.42 USD Mn | 55.04 USD Mn | 46.28 USD Mn | 35.34 USD Mn | 40.65 USD Mn |
| 2017 | 77.25 USD Mn | 69.96 USD Mn | 59.36 USD Mn | 50.12 USD Mn | 38.04 USD Mn | 41.87 USD Mn |
| 2018 | 84.58 USD Mn | 76.45 USD Mn | 64.42 USD Mn | 54.6 USD Mn | 41.2 USD Mn | 43.29 USD Mn |
| 2019 | 97.4 USD Mn | 87.87 USD Mn | 73.52 USD Mn | 62.57 USD Mn | 46.93 USD Mn | 46.94 USD Mn |
| 2020 | 112.81 USD Mn | 101.57 USD Mn | 84.39 USD Mn | 72.11 USD Mn | 53.77 USD Mn | 51.03 USD Mn |
| 2021 | 131.51 USD Mn | 118.17 USD Mn | 97.51 USD Mn | 83.64 USD Mn | 62.01 USD Mn | 55.66 USD Mn |
| 2022 | 154.18 USD Mn | 138.27 USD Mn | 113.3 USD Mn | 97.58 USD Mn | 71.92 USD Mn | 60.82 USD Mn |
| 2023 | 182.09 USD Mn | 162.97 USD Mn | 132.61 USD Mn | 114.67 USD Mn | 84.02 USD Mn | 66.66 USD Mn |
| 2024 | 216.05 USD Mn | 192.98 USD Mn | 155.94 USD Mn | 135.38 USD Mn | 98.61 USD Mn | 73.03 USD Mn |
| 2025 | 257.76 USD Mn | 229.78 USD Mn | 184.39 USD Mn | 160.72 USD Mn | 116.38 USD Mn | 79.99 USD Mn |
Data Source: Wantstats Repository
Market Dynamics
angiotensin receptor neprilysin inhibitors segment accounted for the largest market share in 2018, this market is expected to reach USD 257.76 Million in 2025 from USD 84.58 Million in 2018. This market is projected to grow at a CAGR of 17.61% during the forecast period from 2019 - 2025. However, angiotensin receptor neprilysin inhibitors segment is the fastest growing market, which is expected to grow at a CAGR of 17.61% during the forecast period 2019 - 2025. angiotensin receptor neprilysin inhibitors segment accounted for the largest market share in the heart failure drugs market, and is expected to reach USD 257.76 Million in 2025 from USD 84.58 Million in 2018. However, angiotensin receptor neprilysin inhibitors segment is the fastest growing market, which is expected to grow at a CAGR of 17.61% during the forecast period 2019 - 2025.
Research Methodology
Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2023.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



